The pharmaceutical and biotech sectors, which had been overlooked during the semiconductor-led market rally, have recently shown strong performance. The healthcare index has significantly outperformed the semiconductor index, attracting a surge of foreign buying. Eased U.S. tariff risks and news of global new drug developments and technology transfers are boosting domestic investor sentiment.
Securities firms predict that this trend will continue through the first half of next year. Global trends such as treatments for obesity and metabolic diseases, along with domestic companies’ technology exports and new drug approvals, are having a positive impact, leading analysts to believe there is ample room for further gains. Experts advise, “It is effective to develop a bio investment strategy alongside semiconductors and high-dividend stocks in line with the rotational market expected through the end of the year.”
[Industry No.1 HighStockLoan Direct Link: https://www.hisl.co.kr/5113]
Meanwhile, interest in stock loans continues to rise. Investors eager not to miss rare investment opportunities are turning to stock loans, which allow them to use more capital for stock purchases.
One of the advantages of stock loans is that even if investors face a forced sale crisis due to a sharp drop in stock prices while using margin/credit, they can easily switch to a stock loan without providing additional collateral or selling their holdings, and then wait for a market rebound.
◆ HighStockLoan: Industry’s lowest annual interest rate in the 4% range, offering additional investment funds and even refinancing of margin/credit!
HighStockLoan has launched a securities-linked credit product that anyone can use at the industry’s lowest annual interest rate in the 4% range, making stock loans accessible to all. It can be used not only for stock purchases but also for refinancing margin/credit from securities firms, and up to four times the investor’s own capital can be utilized regardless of credit rating.
Additionally, for investors who previously found it difficult to use stock loans due to DSR limits, a product not subject to DSR is also available. Investors using the alternative trading system (NXT) can also take advantage of these offerings.
Investors interested in HighStockLoan’s various customized products can contact the customer service center (☎1566-5113) for convenient 24-hour professional consultation, regardless of loan approval.
○ Launched product with industry’s lowest annual interest rate in the 4% range
○ Offering products not subject to DSR
○ No.1 market share for 21 consecutive years, winner of the Korea First Brand Award for 16 consecutive years
○ Real-time repayment of margin/credit from securities firms
○ Available for trading on the alternative trading system (NXT)
○ Reliable consultation quality assurance system
* HighStockLoan Consultation Center: 1566-5113
Direct link: https://www.hisl.co.kr/5113
SK Hynix, Samsung Electronics, Doosan Enerbility, ABL Bio, Celltrion
※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
